Company intelligence / Profile preview

BioAssay Works

Ijamsville, Maryland, United Statesbioassayworks.com ↗

Ownership: Private
Employees: ~14
Development stage: Commercial

Overview

BioAssay Works has over two decades of experience developing custom lateral flow immunoassays and reagents. Their patented technologies enable rapid, sensitive point-of-care tests rivaling ELISA sensitivity. They serve both early-stage startups and established companies with turnkey solutions from feasibility through manufacturing. No clinical results as they do not develop therapeutics.

Therapeutic areas: OtherInfectious Diseases
Modalities: Diagnostic deviceLateral flow assay platform technologyNanoparticle-based detection (colloidal gold)Antibody-based detection (immunoassays)
Industry: Protein Biomarker Diagnostics

Partnerships

Not specifically listed in public sources. The company acts as an assay-development partner for various biotech/pharma clients.

Beyond the preview

Go deeper on BioAssay Works.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioAssay Works.

Explore the full profile